Study in healthy volunteers to investigate the effects of Ketoconazole on the Pharmacokinetics of NKTR-118

Study identifier:D3820C00012

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open-label, 1-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 in Healthy Subjects

Medical condition

Bioavailability, Healthy Volunteers, Drug- drug interactions

Phase

Phase 1

Healthy volunteers

Yes

Study drug

NKTR-118, Ketoconazole

Sex

All

Actual Enrollment

22

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Feb 2012
Primary Completion Date: 01 Apr 2012
Study Completion Date: 01 Apr 2012

Study design

Allocation: Non-randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Oct 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria